Partners
MipSalus partners with leading research institutes, medical professionals, and others to develop its breakthrough treatment of Phenylketonuria (PKU) and its home sensor for blood phenylalanine test while refining its proprietary technology platform.
Aarhus University, Denmark
Aarhus University Hospital, Denmark
Linnaeus University, Sweden
Liverpool University, United Kingdom
The Mater Hospital, Ireland
Rigshospitalet, Denmark
Smerud Medical Research International, Norway
University Hospitals Birmingham, United Kingdom
The Environmental Technology Development and Demonstration Program, Denmark
Innovation Fund Denmark
